Danaher Corporation (DHR) : Parnassus Investments Ca reduced its stake in Danaher Corporation by 0.31% during the most recent quarter end. The investment management company now holds a total of 6,548,812 shares of Danaher Corporation which is valued at $532,287,439 after selling 20,384 shares in Danaher Corporation , the firm said in a disclosure report filed with the SEC on Aug 9, 2016.Danaher Corporation makes up approximately 3.12% of Parnassus Investments Ca’s portfolio.
Other Hedge Funds, Including , Penserra Capital Management boosted its stake in DHR in the latest quarter, The investment management firm added 291 additional shares and now holds a total of 840 shares of Danaher Corporation which is valued at $68,494. Danaher Corporation makes up approx 0.01% of Penserra Capital Management’s portfolio.Nippon Life Insurance Co reduced its stake in DHR by selling 2,458 shares or 8.33% in the most recent quarter. The Hedge Fund company now holds 27,063 shares of DHR which is valued at $2,191,562. Danaher Corporation makes up approx 0.05% of Nippon Life Insurance Co’s portfolio.Ramsay Stattman Vela Price boosted its stake in DHR in the latest quarter, The investment management firm added 1,925 additional shares and now holds a total of 75,473 shares of Danaher Corporation which is valued at $6,101,992. Danaher Corporation makes up approx 2.94% of Ramsay Stattman Vela Price’s portfolio.Nn Investment Partners Holdings N.v. boosted its stake in DHR in the latest quarter, The investment management firm added 5,439 additional shares and now holds a total of 133,862 shares of Danaher Corporation which is valued at $10,848,176. Danaher Corporation makes up approx 0.10% of Nn Investment Partners Holdings N.v.’s portfolio.
Danaher Corporation opened for trading at $80.82 and hit $81.05 on the upside on Wednesday, eventually ending the session at $81.02, with a gain of 0.40% or 0.32 points. The heightened volatility saw the trading volume jump to 16,06,048 shares. Company has a market cap of $55,947 M.
On the company’s financial health, Danaher Corporation reported $1.25 EPS for the quarter, beating the analyst consensus estimate by $ 0.03 according to the earnings call on Jul 25, 2016. Analyst had a consensus of $1.22. The company had revenue of $5785.00 million for the quarter, compared to analysts expectations of $5766.84 million. The company’s revenue was up 16.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.08 EPS.
Many Wall Street Analysts have commented on Danaher Corporation. Shares were Reiterated by Barclays on Jul 11, 2016 to “Overweight” and Lowered the Price Target to $ 86 from a previous price target of $105 .Danaher Corporation was Initiated by Goldman to “Neutral” on Jul 5, 2016. Danaher Corporation was Upgraded by Bernstein to ” Outperform” on Jun 24, 2016.
Danaher Corporation (Danaher) designs manufactures and markets professional medical industrial and commercial products and services. It operates in five segments: Test & Measurement; Environmental; Life Sciences & Diagnostics; Dental and Industrial Technologies. The Test & Measurement segment offers test measurement and monitoring products. The Environmental segment products and services help protect the global water supply facilitate environmental stewardship and enhance the safety of personal data. The Companys diagnostics business offers analytical instruments reagents consumables software and services. The Dental segment provides products that are used to diagnose treat and prevent disease and ailments of the teeth gums and supporting bone. The Companys Industrial Technologies solutions help protect the worlds food supply improve packaging design and quality verify pharmaceutical dosages and authenticity and power innovative machines.